Illuminating the Druggable Genome

Researchers supported by the IDG program will work with Nature Reviews Drug Discovery (NRDD) to develop new content on a regular basis highlighting understudied protein targets. Read the articles below to learn more about the IDG program and new proteins of interest.

• K_Na1.1 channels as a target for treating early-onset epilepsy
  May 13, 2020
   
• PIP5K1A: a potential target for cancers with KRAS or TP53 mutations
  April 24, 2020
   
• Novel drug targets in 2019
  April 9, 2020
   
• GPR84: An immune response dial?
  February 20, 2020
   
• PKMYT1: A forgotten member of the WEE1 family
  November 26, 2019
   
• ADCK3/COQ8a: The choice target of the UbiB protein kinase-like family
  September 16, 2019
   
• TRIC-B: an under-explored druggable ion channel
  July 26, 2019
   
• RIOK2:Straddling the kinase/ATPase line
  June 26, 2019
   
• CDK16: the pick of the understudied PCTAIRE kinases
  May 21, 2019
   
• Novel drug targets in 2018
  March 26, 2019